S. 744Senate116th Congress (2019-2021)Enacted

Effective Prosecution of Possession of Biological Toxins and Agents Act of 2019

A bill to amend section 175b of title 18, United States Code, to correct a scrivener's error.

Introduced March 12, 2019

Legislative Activity

Stay on top of the latest movement without scrolling through every action

15 earlier actions
Became Law Latest Action

Became Public Law No: 116-31.

July 25, 2019

View full timeline
SenateIntro Referral

Introduced in Senate

March 12, 2019

SenateIntro Referral

Read twice and referred to the Committee on the Judiciary.

March 12, 2019

SenateDischarge

Senate Committee on the Judiciary discharged by Unanimous Consent. (consideration: CR S2929)

May 16, 2019

SenateFloor

Passed Senate without amendment by Unanimous Consent. (text: CR S2929)

May 16, 2019

SenateFloor

Message on Senate action sent to the House.

May 20, 2019

HouseFloor

Received in the House.

May 20, 2019 • 2:03 PM

HouseIntro Referral

Referred to the House Committee on the Judiciary.

May 20, 2019

HouseCommittee

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

May 31, 2019

HouseFloor

Ms. Bass moved to suspend the rules and pass the bill.

July 10, 2019 • 3:49 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H5331-5332)

July 10, 2019 • 3:49 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on S. 744.

July 10, 2019 • 3:49 PM

HouseFloor

On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5331)

July 10, 2019 • 3:55 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

July 10, 2019 • 3:55 PM

President

Presented to President.

July 15, 2019

Became Law

Signed by President.

July 25, 2019

Became Law

Became Public Law No: 116-31.

July 25, 2019

Floor Debate

4 members

What members said about S. 744 on the floor

2 Republicans2 Democrats
Karen Bass
Rep. Karen BassD-CA-37 · Jul 10, 2019

Mr. Speaker, I move to suspend the rules and pass the bill (S. 744) to amend section 175b of title 18, United States Code, to correct a scrivener's error. Mr. Speaker, I ask unanimous consent that…

Sheila Jackson Lee
Rep. Sheila Jackson LeeD-TX-18 · Jul 10, 2019

Mr. Speaker, as a senior member of the Committees on the Judiciary and on Homeland Security, I rise in strong support of S. 744 the ``Effective Prosecution of Biological Toxins and Agents,'' which…

Doug Collins
Rep. Doug CollinsR-GA-9 · Jul 10, 2019

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I also rise in support of H.R. 1986 because it fixes a technical, but very important, error that occurred in the Code, and the…

Mitch McConnell
Sen. Mitch McConnellR-KY · May 16, 2019

Mr. President, I ask unanimous consent that the Committee on the Judiciary be discharged from further consideration of S. 744 and the Senate proceed to its immediate consideration. I ask unanimous…

Bill Text

5 versions available

Reading Mode
Latest
Enrolled BillIssued July 12, 2019

One Hundred Sixteenth Congress of the United States of America

1st Session

Begun and held at the City of Washington on Thursday, the third day of January, two thousand and nineteen

S. 744

AN ACT

To amend section 175b of title 18, United States Code, to correct a scrivener’s error.

1.

Short title

This Act may be cited as the Effective Prosecution of Possession of Biological Toxins and Agents Act of 2019.

2.

Prohibition on the possession of biological toxins and agents

Section 175b of title 18, United States Code, is amended—

(1)

in subsection (a)—

(A)

by striking (a)(1) No restricted and all that follows through the end of paragraph (1) and inserting the following:

(a)

Offense

(1)

In general

It shall be unlawful for a restricted person to—

(A)

ship, transport, or possess in or affecting interstate or foreign commerce any biological agent or toxin described in paragraph (2); or

(B)

receive any biological agent or toxin described in paragraph (2) that has been shipped or transported in interstate or foreign commerce.

(2)

Agents and toxins covered

A biological agent or toxin described in this paragraph is a biological agent or toxin that—

(A)

is listed as a non-overlap or overlap select biological agent or toxin under part 73 of title 42, Code of Federal Regulations, pursuant to section 351A of the Public Health Service Act (42 U.S.C. 262a); and

(B)

is not excluded or exempted under part 73 of title 42, Code of Federal Regulations.

; and

(B)

by striking (2) Whoever and inserting (3) Penalty.—Whoever and adjusting the margin accordingly; and

(2)

in subsection (d), in the matter preceding paragraph (1), by inserting Definitions.— before In this section:.

Speaker of the House of Representatives

Vice President of the United States and President of the Senate